Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infant botulism: case report and clinical update.

A Jagoda1, G Renner

  • 1Department of Emergency Medicine, Bethesda Naval Hospital, MD.

The American Journal of Emergency Medicine
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new in vitro approach for determining the water resistance of sunscreen products, validated by a blinded ring test.

International journal of cosmetic science·2025
Same author

Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.

Cell death and differentiation·2015
Same author

Assessment of undesirable events in cosmetic market surveillance: background, description and use of a causality assessment method in cosmetovigilance.

Regulatory toxicology and pharmacology : RTP·2010
Same author

International comparison of performance measures for screening mammography: can it be done?

Journal of medical screening·2004
Same author

Psychiatric commitment: patients' perspectives.

Medicine and law·2003
Same author

Indicators of quality of in-patient psychiatric treatment: the patients' view.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2003

Infant botulism, caused by Clostridium botulinum toxin, affects infants under 11 months. Treatment is supportive care, with antibiotics and antitoxin not recommended, leading to a less than 3% mortality rate.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Toxicology

Background:

  • Infant botulism is a rare but serious condition affecting infants from 1 week to 11 months old.
  • It is caused by the neurotoxin produced by Clostridium botulinum bacteria within the infant's body.

Observation:

  • Clinical presentation varies from asymptomatic cases to severe paralysis and even sudden death.
  • Classic symptoms include constipation, generalized weakness, poor head control, weak suck, and weak cry.
  • Progression can lead to cranial nerve palsies, respiratory arrest, and adynamic ileus.

Findings:

  • Treatment focuses on supportive care in an intensive care setting.
  • Antibiotics and antitoxin are not indicated for infant botulism.
  • Morbidity and mortality rates are less than 3% in hospitalized infants, with complete recovery expected.

Related Experiment Videos

Implications:

  • Understanding environmental and dietary risk factors is crucial for prevention.
  • Early recognition of symptoms can lead to timely supportive care and improved outcomes.
  • This condition highlights the importance of recognizing toxin-mediated diseases in infants.